| Dexamethasone 6 mg/m2 (n = 34) | Prednisone 40 mg/m2 (n = 28) | Total (n = 62) | OR | 95% CI | P-value | |||
| n | % | n | % | n | % |
|
|
|
Induction treatment |
|
|
|
|
|
|
|
|
|
Complete remission | 23 | 67.6 | 19 | 67.9 | 42 | 67.7 |
|
|
|
Induction failures | 11 | 32.4 | 9 | 32.3 | 20 | 32.3 | 0.99 | 0.34 - 2.89a | 0.992 |
Abandonment | 4 | 11.8 | 4 | 14.3 | 8 | 12.9 | 1.21 | 0.27 - 5.50a | 1.002 |
Death | 3 | 8.8 | 4 | 14.3 | 7 | 11.3 | 1.61 | 0.32 - 8.12a | 0.692 |
Resistant disease | 4 | 11.8 | 1 | 3.7 | 5 | 8.1 | 0.30 | 0.03 - 2.94a | 0.382 |
Overall events |
|
|
|
|
|
|
|
|
|
Continuous CR | 14 | 41.2 | 11 | 39.3 | 25 | 40.3 |
|
|
|
Treatment failures | 20 | 58.8 | 17 | 60.7 | 37 | 59.7 | 1.08 | 0.39 - 3.00b | 0.881 |
Abandonment | 9 | 26.5 | 10 | 35.7 | 19 | 30.6 | 1.41 | 0.43 - 4.68b | 0.571 |
Death | 5 | 14.7 | 5 | 17.8 | 10 | 16.2 | 1.27 | 0.29 - 5.55b | 1.002 |
Leukemic event | 6 | 17.6 | 2 | 7.2 | 8 | 12.9 | 0.42 | 0.07 - 2.53b | 0.432 |